PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Ophthalmology Mediterranean Foundation (FOM), Valencia, Spain.\', \'Department of Optometry and Vision Science, Universitat de Valencia, Valencia, Spain.\', \'Department of Ophthalmology, Antwerp University Hospital (UZA), Antwerp, Belgium.\', \'Faculty of Medicine and Health Sciences, Antwerp University, Antwerp, Belgium.\', \'Ophthalmology Department, University Hospital Miguel Servet (HUMS), Zaragoza, Spain.\', \'Aragon Health Research Institute (IISA), Zaragoza, Spain.\', \'Department of Community Nursing, Preventive Medicine and Public Health and History of Science, Public Health Research Group, University of Alicante, Spain.\', \'Department of Optics, Pharmacology and Anatomy, Science Faculty, University of Alicante, Spain.\', \'Alicante Health and Biomedical Research Institute (ISABIAL), Alicante University General Hospital, Alicante, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1177/1120672120958323
?:hasPublicationType
?:journal
  • European journal of ophthalmology
is ?:pmid of
?:pmid
?:pmid
  • 33829895
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.763
?:rankingScore_hIndex
  • 46
is ?:relation_isRelatedTo_publication of
?:title
  • What can visual caregivers expect with patients treated for SARS-CoV-2? An analysis of ongoing clinical trials and ocular side effects.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all